Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piroxicam vs Prednisolone for Post Endodontic Pain
NCT04124822Phase 3Completed
- Sponsor
- Dow University of Health Sciences
- Start
- May 2018
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of piroxicam, prednisolone in post-operative endodontic pain (PEP), sponsored by Dow University of Health Sciences. Started May 2018; status: completed.
02
Drugs
piroxicamprednisolone
03
Conditions
post-operative endodontic pain (PEP)
Beyond the preview
Go deeper on NCT04124822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04124822.